TY - JOUR T1 - Consultagene: Pre- and Post-Pandemic Experience with a Web-based Platform and Remote Delivery of Genetic Services JF - medRxiv DO - 10.1101/2021.01.20.21249267 SP - 2021.01.20.21249267 AU - Kim C. Worley AU - Daniel Lee Riconda AU - Amy M. Wallis AU - Chad A. Shaw AU - Chris M. Holder AU - Salma A. Nassef AU - Sandra Darilek AU - Seema R. Lalani AU - Pilar L. Magoulas AU - Sarah M. Huguenard AU - Brendan H. L. Lee Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/26/2021.01.20.21249267.abstract N2 - Changes in genetics and genomics sequencing in recent years have created increased demand for genetics professionals, including clinical geneticists and genetic counselors. A significant workforce shortage of these professionals has become widely recognized. This shortage is driven by several factors, including the increased role of genetics in healthcare due to precision medicine initiatives and demand outside of medical practices in clinical and direct-to-consumer genetic testing companies that require genetics professionals for education and counseling.We developed the Consultagene virtual platform for delivery of genetic care, counseling, and education to address some of these issues that have become global challenges in the field of clinical genetics and to bridge existing gaps at the point of care. The platform provides access to specific content based upon the referral indication including educational videos and resource links, allows document sharing, health and history information gathering and appointment scheduling with persistent access to the materials via secure data infrastructure. Having the platform coupled with access to our tele- and video consultation service allows clients convenient on-demand access to genetic education and services as needed.This report describes the Consultagene platform development and use prior to and during the COVID-19 pandemic, some of the identified strengths and weaknesses of such a platform, and the current applications in the new environment where telemedicine practice has rapidly expanded.Topic Summary Consultagene is the first academic virtual platform to integrate a comprehensive range of genetics services including genetics education, genetics consultation, and genetic counseling. Consultagene addresses the increasing demands and unmet, evolving needs for genetic services due to widely available genomic sequencing and the platform seamlessly adapted to the pandemic-induced adjustments to clinical practice.Competing Interest StatementThe Baylor Genetics Laboratory is a joint venture between the Department of Molecular and Human Genetics at Baylor College of Medicine and H.U.Group Holdings, the authors are faculty and employees in the department and benefit indirectly from this arrangement. The authors declare no other conflicts of interest with this work.Funding StatementNo external funding supported this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Amara Azobu, MSc, CIP, Director, Research Compliance, Institutional Review Board (IRB) Administrator, Research Oversight Administration, Baylor College of Medicine, Office of Research provided an email indicating that had it been submitted for prior review, the IRB would have given it a determination indicating that it is not research requiring IRB review. The survey data work meets the exemption requirement for Exemption 45 CFR 46.104(d)(2) for Educational Tests, Surveys, Interviews, or Observation of Public Behavior.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe survey data reported is provided in the supplemental information. The Consultagene clinic can be reached via the web site www.consultagene.org. Contact the authors for information about adopting the Consultagene platform. ER -